Mammography Devices Market to Grow with a CAGR of 5.77% through 2028
Increasing prevalence of breast cancer and technological advancements in
breast imaging is expected to drive the Global Mammography Devices Market
growth in the forecast period, 2024-2028.
According to TechSci Research report, “Mammography
Devices Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Mammography Devices Market stood at
USD 2.43 billion in 2022 and is anticipated to grow with a CAGR of 5.77% in the
forecast period, 2024-2028. The increasing awareness surrounding breast cancer
and the necessity of screening treatment through government campaigns and NGO
initiatives have led to a surge in demand for Mammography systems, thereby
driving market growth.
The prevalence of breast cancer in the elderly
population is on the rise, and the utilization of hormone replacement therapy
(HRT) is increasing, emphasizing the global need for breast imaging diagnostic
solutions.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Mammography Devices Market.”
The growth of mammography devices can be attributed to
the increasing prevalence of breast cancer worldwide. Breast cancer is a
terminal disease, and early diagnosis is often challenging, posing a greater
threat to life. Mammography devices assist in identifying any abnormalities in
the mammary glands, aiding in the detection of cancer. This, in turn, is
expected to drive market growth.
Furthermore, supportive government policies and
initiatives worldwide aimed at raising awareness among the female population
about breast cancer and its symptoms are anticipated to fuel market growth
through 2026. In addition, various non-governmental organizations, hospitals,
and public welfare organizations continue to organize camps and awareness
campaigns to spread knowledge about breast cancer. All these factors are
expected to have a positive impact on the market in the coming years.
The rising utilization of medical care, a flourishing
medical services industry, and an increasing demand for regular monitoring are
among the key drivers expected to propel the demand for mammography machines in
the future. Growing government initiatives to enhance clinical translation and
improve access to breast cancer screening systems are likely to drive demand
throughout the forecast period. Furthermore, the Health Resources and Services
Administration (HRSA) has implemented the Federal Consolidated Health Centers
Programs to enhance screening processes in medically underserved communities.
New York State is also supporting access to early breast cancer screening under
Governor Cuomo's leadership. The aforementioned efforts aim to assist patients
whose family income falls below the federal poverty line.
The increasing prevalence of breast cancer and the
growing demand for early-stage diagnosis among patients are some of the key
factors expected to drive the demand for breast cancer diagnostic devices in
the forecast period. Increased access to breast cancer screening systems and
government initiatives to support clinical understanding are also crucial
factors expected to promote market growth. For instance, the Health Resources
and Services Administration (HRSA) has introduced a healthcare program to increase
screening procedures in medically underserved areas.
According to reports from the Centers for Disease
Control and Prevention (CDC) in 2018, breast cancer is a prevalent form of
cancer among women, regardless of race or ethnicity. It is also the third
leading cause of cancer-related deaths among American Indian/Alaska Native
women. Globocan's 2020 report revealed that breast cancer had the highest
prevalence rate at 11.7%, making it the most common type of cancer. The
five-year prevalence rate showed Asia having the largest number of affected
individuals at 3,218,496 (41.3%), followed by Europe with 2,138,117 (27.4%),
and North America with 1,189,111 people (15.3%). The high prevalence of breast
cancer worldwide is a significant driving factor for the growth of the
mammography devices market. Additionally, the global population is aging, with
age being considered a risk factor for breast cancer. Women aged 60 years and
above account for nearly 78% of all breast cancer-related deaths. As breast
cancer can be invasive, early diagnosis and routine checkups are crucial for
women of all age groups.
The market for mammography devices is projected to
expand favorably throughout the forecast period. This is due to the system's
ability to capture high-contrast, high-quality electronic images of the breast
with minimal physical compression. Additionally, it offers soft-copy image
displays and reading for easy data transfer. Moreover, it enables important
advancements in breast cancer diagnosis, including improved detection, reduced
radiation doses, and reduced breast compression pressure, which are expected to
contribute to market growth.
The Global Mammography Devices Market is segmented
into product type, technology, end user, regional distribution, and company.
Based on technology, the Digital Mammography segment
is projected to hold a significant market share during the forecast period. Due
to the higher risk of infection among breast cancer patients, numerous
organizations have implemented specific measures to manage these diseases. In a
research article published in the Medicina Clínica Journal in September 2020 by
Dafina Petrova et al., recommendations were provided by the European Society
for Medical Oncology (ESMO), the Spanish Society of Radiation Oncology (SEOR),
and the Spanish Society of Medical Oncology (SEOM) on modifying treatment
protocols to minimize risks for cancer patients. These enhanced guidelines are
expected to improve surgical procedures and positively impact treatments,
thereby supporting the growth of the digital mammography market.
The adoption of digital mammography is increasing
globally, as it offers superior depiction of low-contrast objects, wider
dynamic range, and improved diagnostic image quality, particularly for denser
breasts. Furthermore, product launches have contributed to the growth of this
segment. For example, in August 2021, FUJIFILM Medical Systems U.S.A., Inc.
introduced ScreenPoint Medical's FDA cleared Transpara powered by Fusion AI for
2D and 3D mammography in the United States. Additionally, in April 2021, Fujifilm
Europe GmbH launched the "Harmony" version of its Amulet Innovality
mammography system in Germany. AMULET Innovality is a Full Field Digital
Mammography (FFDM) system equipped with Fujifilm's innovative technologies that
deliver optimal image quality at a significantly low patient dose. Despite the
higher cost compared to conventional systems, digital mammography is
increasingly becoming the preferred choice for screening.
Based on region, North America segment is expected to
grow during the forecast period. North America dominates the global mammography
market, exhibiting a consistent trend throughout the forecast period. The
region's substantial market share can be attributed to the increasing
prevalence of breast cancer and the presence of robust healthcare
infrastructure. According to the American Cancer Society, an estimated 276,480
new cases of invasive breast cancer were diagnosed among women in 2020, with an
additional 48,530 cases of in situ breast carcinoma. This number is projected
to rise in the coming years. To support breast cancer testing, various
companies have launched initiatives, such as Hologic Inc.'s Back to Screening
campaign, aimed at encouraging women to schedule their delayed mammograms due
to the COVID-19 pandemic. Furthermore, the market growth is driven by the
introduction and widespread adoption of advanced mammography devices featuring
innovative technologies. For example, FUJIFILM Canada Inc. obtained a Health
Canada medical device license for its ASPIRE Cristalle digital mammography
solution in October 2021, and expanded its partnership with Christie Innomed to
make the product available across all provinces in Canada. With the increasing
prevalence of breast cancer and the launch of new products, the market is
poised for growth during the forecast period.
Major companies operating in Global Mammography
Devices Market are:
- Hologic, Inc.
- Fujifilm Holdings Corporation
- Philips Healthcare
- Siemens Healthineers AG
- GE Healthcare
- Carestream Health, Inc.
- Konica Minolta Inc.
- Delphinus Medical Technologies, Inc.
- Analogic Corporation
- KUB Technologies, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The increasing global prevalence of breast cancer is
a key driver for market growth. Furthermore, growing awareness of available
treatment options, the benefits of screening and early diagnosis, and
technological advancements in imaging solutions are additional factors fueling
this growth. For example, innovative 3-Dimensional, non-ionizing, and ionizing
imaging solutions such as Full-field digital mammography (FFDM) and Digital
Breast Tomosynthesis (DBT) systems provide enhanced precision through the generation
of 3D image sets. Additionally, the availability of rental services for digital
mammography systems in public hospitals and diagnostic centers contributes to
market expansion by providing cost-effective imaging solutions. Significant
improvements in healthcare infrastructure and favorable government policies
promoting public health are also expected to drive market growth.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Mammography Devices Market Segmented By Product
Type (Full-field Digital Mammography, Film-screen Mammogram, Breast
Tomosynthesis), By Technology (Digital v/s Analog), By End User (Hospitals
& Clinics, Diagnostic Centers, Others), By Region and Competition, Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Mammography Devices Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Mammography Devices Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com